Literature DB >> 11560953

Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL.

A K Groen1, V W Bloks, R H Bandsma, R Ottenhoff, G Chimini, F Kuipers.   

Abstract

The ABC transporter ABCA1 regulates HDL levels and is considered to control the first step of reverse cholesterol transport from the periphery to the liver. To test this concept, we studied the effect of ABCA1 deficiency on hepatic metabolism and hepatobiliary flux of cholesterol in mice. Hepatic lipid contents and biliary secretion rates were determined in Abca1(-/-), Abca1(+/-), and Abca1(+/+) mice with a DBA background that were fed either standard chow or a high-fat, high-cholesterol diet. Hepatic cholesterol and phospholipid contents in Abca1(-/-) mice were indistinguishable from those in Abca1(+/-) and Abca1(+/+) mice on both diets. In spite of the absence of HDL, biliary secretion rates of cholesterol, bile salts, and phospholipid were unimpaired in Abca1(-/-) mice. Neither the hepatic expression levels of genes controlling key steps in cholesterol metabolism nor the contribution of de novo synthesis to biliary cholesterol and bile salts were affected by Abca genotype. Finally, fecal excretion of neutral and acidic sterols was similar in all groups. We conclude that plasma HDL levels and ABCA1 activity do not control net cholesterol transport from the periphery via the liver into the bile, indicating that the importance of HDL in reverse cholesterol transport requires re-evaluation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11560953      PMCID: PMC200929          DOI: 10.1172/JCI12473

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  60 in total

1.  High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion.

Authors:  D L Silver; N Wang; X Xiao; A R Tall
Journal:  J Biol Chem       Date:  2001-04-11       Impact factor: 5.157

2.  Effect of up-regulating individual steps in the reverse cholesterol transport pathway on reverse cholesterol transport in normolipidemic mice.

Authors:  K Alam; R S Meidell; D K Spady
Journal:  J Biol Chem       Date:  2001-02-20       Impact factor: 5.157

3.  Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter.

Authors:  O Chambenoit; Y Hamon; D Marguet; H Rigneault; M Rosseneu; G Chimini
Journal:  J Biol Chem       Date:  2001-01-09       Impact factor: 5.157

Review 4.  The metabolic role of lecithin: cholesterol acyltransferase: perspectives form pathology.

Authors:  J A Glomset; K R Norum
Journal:  Adv Lipid Res       Date:  1973

Review 5.  Liposomes in vivo; conversion of liposomal cholesterol to bile salts.

Authors:  G L Scherphof; F Kuipers; J T Derksen; H H Spanjer; R J Vonk
Journal:  Biochem Soc Trans       Date:  1987-12       Impact factor: 5.407

6.  Studies on the origin of biliary phospholipid. Effect of dehydrocholic acid and cholic acid infusions on hepatic and biliary phospholipids.

Authors:  F Chanussot; H Lafont; J Hauton; B Tuchweber; I Yousef
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

7.  ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism.

Authors:  W Drobnik; B Lindenthal; B Lieser; M Ritter; T Christiansen Weber; G Liebisch; U Giesa; M Igel; H Borsukova; C Büchler; W P Fung-Leung; K Von Bergmann; G Schmitz
Journal:  Gastroenterology       Date:  2001-04       Impact factor: 22.682

8.  Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice.

Authors:  P Mardones; V Quiñones; L Amigo; M Moreno; J F Miquel; M Schwarz; H E Miettinen; B Trigatti; M Krieger; S VanPatten; D E Cohen; A Rigotti
Journal:  J Lipid Res       Date:  2001-02       Impact factor: 5.922

9.  Origin of biliary cholesterol and lecithin in the rat: contribution of new synthesis and preformed hepatic stores.

Authors:  S J Robins; H Brunengraber
Journal:  J Lipid Res       Date:  1982-05       Impact factor: 5.922

10.  Lipoproteins and liposomes as in vivo cholesterol vehicles in the rat: preferential use of cholesterol carried by small unilamellar liposomes for the formation of muricholic acids.

Authors:  F Kuipers; H H Spanjer; R Havinga; G L Scherphof; R J Vonk
Journal:  Biochim Biophys Acta       Date:  1986-05-21
View more
  37 in total

1.  Is it time to modify the reverse cholesterol transport model?

Authors:  A R Tall; N Wang; P Mucksavage
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 2.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 3.  The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

Authors:  Menno Vergeer; Adriaan G Holleboom; John J P Kastelein; Jan Albert Kuivenhoven
Journal:  J Lipid Res       Date:  2010-04-06       Impact factor: 5.922

Review 4.  A new framework for reverse cholesterol transport: non-biliary contributions to reverse cholesterol transport.

Authors:  Ryan-E Temel; J-Mark Brown
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

Review 5.  From blood to gut: direct secretion of cholesterol via transintestinal cholesterol efflux.

Authors:  Carlos L J Vrins
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

Review 6.  Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches.

Authors:  Emil M deGoma; Rolando L deGoma; Daniel J Rader
Journal:  J Am Coll Cardiol       Date:  2008-06-10       Impact factor: 24.094

7.  Origins of intestinal ABCA1-mediated HDL-cholesterol.

Authors:  F Jeffrey Field; Kim Watt; Satya N Mathur
Journal:  J Lipid Res       Date:  2008-08-18       Impact factor: 5.922

Review 8.  A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion.

Authors:  Ryan E Temel; J Mark Brown
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

9.  In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1.

Authors:  Adriaan G Holleboom; Lily Jakulj; Remco Franssen; Julie Decaris; Menno Vergeer; Joris Koetsveld; Jayraz Luchoomun; Alexander Glass; Marc K Hellerstein; John J P Kastelein; G Kees Hovingh; Jan Albert Kuivenhoven; Albert K Groen; Scott M Turner; Erik S G Stroes
Journal:  J Lipid Res       Date:  2013-05-06       Impact factor: 5.922

Review 10.  Dynamics of hepatic and intestinal cholesterol and bile acid pathways: The impact of the animal model of estrogen deficiency and exercise training.

Authors:  Jean-Marc Lavoie
Journal:  World J Hepatol       Date:  2016-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.